These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7645975

  • 1. Discordant effects of butyrate analogues on erythroleukemia cell proliferation, differentiation and histone deacetylase.
    Lea MA, Tulsyan N.
    Anticancer Res; 1995; 15(3):879-83. PubMed ID: 7645975
    [Abstract] [Full Text] [Related]

  • 2. Induction of histone acetylation and growth regulation in eryrthroleukemia cells by 4-phenylbutyrate and structural analogs.
    Lea MA, Randolph VM, Hodge SK.
    Anticancer Res; 1999; 19(3A):1971-6. PubMed ID: 10470142
    [Abstract] [Full Text] [Related]

  • 3. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T, Kennedy C, Chiew YE, Clarke CL, deFazio A.
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [Abstract] [Full Text] [Related]

  • 4. Butyramide and monobutyrin: growth inhibitory and differentiating agents.
    Lea MA, Xiao Q, Sadhukhan A, Sharma S, Newmark HL.
    Anticancer Res; 1993 Nov; 13(1):145-9. PubMed ID: 8476205
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationship of butyrate analogues on apoptosis, proliferation and histone deacetylase activity in HCT-116 human colorectal cancer cells.
    Ooi CC, Good NM, Williams DB, Lewanowitsch T, Cosgrove LJ, Lockett TJ, Head RJ.
    Clin Exp Pharmacol Physiol; 2010 Sep; 37(9):905-11. PubMed ID: 20497425
    [Abstract] [Full Text] [Related]

  • 6. Possible mechanism of action of the histone deacetylase inhibitors for the induction of differentiation of HL-60 clone 15 cells into eosinophils.
    Ishihara K, Hong J, Zee O, Ohuchi K.
    Br J Pharmacol; 2004 Jul; 142(6):1020-30. PubMed ID: 15210580
    [Abstract] [Full Text] [Related]

  • 7. Induction of histone acetylation and inhibition of growth by phenyl alkanoic acids and structurally related molecules.
    Lea MA, Shareef A, Sura M, desBordes C.
    Cancer Chemother Pharmacol; 2004 Jul; 54(1):57-63. PubMed ID: 15034756
    [Abstract] [Full Text] [Related]

  • 8. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor.
    Nakamura M, Saito H, Ebinuma H, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Ishii H.
    J Cell Physiol; 2001 Jun; 187(3):392-401. PubMed ID: 11319763
    [Abstract] [Full Text] [Related]

  • 9. p21Waf1/Cip1 is a common target induced by short-chain fatty acid HDAC inhibitors (valproic acid, tributyrin and sodium butyrate) in neuroblastoma cells.
    Rocchi P, Tonelli R, Camerin C, Purgato S, Fronza R, Bianucci F, Guerra F, Pession A, Ferreri AM.
    Oncol Rep; 2005 Jun; 13(6):1139-44. PubMed ID: 15870934
    [Abstract] [Full Text] [Related]

  • 10. Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors.
    Ishihara K, Takahashi A, Kaneko M, Sugeno H, Hirasawa N, Hong J, Zee O, Ohuchi K.
    Life Sci; 2007 Mar 06; 80(13):1213-20. PubMed ID: 17258775
    [Abstract] [Full Text] [Related]

  • 11. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
    Savickiene J, Borutinskaite VV, Treigyte G, Magnusson KE, Navakauskiene R.
    Eur J Pharmacol; 2006 Nov 07; 549(1-3):9-18. PubMed ID: 16978604
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of histone deacetylation by butyrate induces morphological changes in Y79 retinoblastoma cells.
    Karasawa Y, Okisaka S.
    Jpn J Ophthalmol; 2004 Nov 07; 48(6):542-51. PubMed ID: 15592778
    [Abstract] [Full Text] [Related]

  • 13. Mechanism of the eosinophilic differentiation of HL-60 clone 15 cells induced by n-butyrate.
    Ishihara K, Hong J, Zee O, Ohuchi K.
    Int Arch Allergy Immunol; 2005 Nov 07; 137 Suppl 1():77-82. PubMed ID: 15947489
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor alpha expression is regulated by estrogen receptor alpha and modulates the response of MCF-7 cells to sodium butyrate.
    Faddy HM, Robinson JA, Lee WJ, Holman NA, Monteith GR, Roberts-Thomson SJ.
    Int J Biochem Cell Biol; 2006 Feb 07; 38(2):255-66. PubMed ID: 16226051
    [Abstract] [Full Text] [Related]

  • 15. Effects of histone deacetylase inhibitors, sodium phenyl butyrate and vitamin B3, in combination with retinoic acid on granulocytic differentiation of human promyelocytic leukemia HL-60 cells.
    Merzvinskyte R, Treigyte G, Savickiene J, Magnusson KE, Navakauskiene R.
    Ann N Y Acad Sci; 2006 Dec 07; 1091():356-67. PubMed ID: 17341628
    [Abstract] [Full Text] [Related]

  • 16. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM, Liu JC.
    J Cell Physiol; 2009 Mar 07; 218(3):568-74. PubMed ID: 19006173
    [Abstract] [Full Text] [Related]

  • 17. Altered queuine modification of transfer RNA involved in the differentiation of human K562 erythroleukemia cells in the presence of distinct differentiation inducers.
    Chen YL, Wu RT.
    Cancer Res; 1994 Apr 15; 54(8):2192-8. PubMed ID: 7513611
    [Abstract] [Full Text] [Related]

  • 18. K562 human erythroleukemia cell variants resistant to growth inhibition by butyrate have deficient histone acetylation.
    Ohlsson-Wilhelm BM, Farley BA, Kosciolek B, La Bella S, Rowley PT.
    Am J Hum Genet; 1984 Nov 15; 36(6):1225-38. PubMed ID: 6595945
    [Abstract] [Full Text] [Related]

  • 19. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate.
    Sekhavat A, Sun JM, Davie JR.
    Biochem Cell Biol; 2007 Dec 15; 85(6):751-8. PubMed ID: 18059533
    [Abstract] [Full Text] [Related]

  • 20. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma.
    Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O.
    Eur J Haematol; 2006 Jan 15; 76(1):42-50. PubMed ID: 16343270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.